Our investigation revealed new aspects of ACTN4 functions in human cells, since the involvement of ACTN4 in the DSB repair process and, consequently, modulation of cancer cell resistance to genotoxic drugs have not yet been described. This evidence concerns the gene ACTN4 and cancer.